Langue NL EN DE ES FR UK IT

Analyse de reconstruction

Analyse Cartel

Base propre pour l’analyse de réseaux de députés européens, de documents et de thèmes. Pas d’étiquettes politiques rigides, mais des preuves vérifiables.

You are here

Online public consultation on the extension of the EU Digital COVID Certificate

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

Online public consultation on the extension of the EU Digital COVID Certificate

EP schriftelijke vraag met voorrang | - | source: parliamentary_questions

Open bronpagina Leesbare metadata Wikipedia zoeken

Pfizer en covid

23Actors

1Signals

9EP term

Actors

Annika Bruna

Role: co-author

Method: name-normalized | confidence 0.7500

Bernhard Zimniok

Role: co-author

Method: name-normalized | confidence 0.7500

Bert-Jan Ruissen

Role: co-author

Method: name-normalized | confidence 0.7500

Catherine Griset

Role: co-author

Method: name-normalized | confidence 0.7500

Elżbieta Kruk

Role: co-author

Method: name-normalized | confidence 0.7500

Francesca Donato

Role: co-author

Method: name-normalized | confidence 0.7500

Gerolf Annemans

Role: co-author

Method: name-normalized | confidence 0.7500

Gilles Lebreton

Role: co-author

Method: name-normalized | confidence 0.7500

Guido Reil

Role: co-author

Method: name-normalized | confidence 0.7500

Hélène Laporte

Role: co-author

Method: name-normalized | confidence 0.7500

Ivan Vilibor Sinčić

Role: co-author

Method: name-normalized | confidence 0.7500

Jaak Madison

Role: co-author

Method: name-normalized | confidence 0.7500

Jean-François Jalkh

Role: co-author

Method: name-normalized | confidence 0.7500

Jean-Paul Garraud

Role: co-author

Method: name-normalized | confidence 0.7500

Jorge Buxadé Villalba

Role: co-author

Method: name-normalized | confidence 0.7500

Ladislav Ilčić

Role: co-author

Method: name-normalized | confidence 0.7500

Laura Huhtasaari

Role: co-author

Method: name-normalized | confidence 0.7500

Marco Campomenosi

Role: co-author

Method: name-normalized | confidence 0.7500

Milan Uhrík

Role: co-author

Method: name-normalized | confidence 0.7500

Nicolaus Fest

Role: co-author

Method: name-normalized | confidence 0.7500

Rob Rooken

Role: co-author

Method: name-normalized | confidence 0.7500

Tom Vandendriessche

Role: co-author

Method: name-normalized | confidence 0.7500

Virginie Joron

Role: co-author

Method: name-normalized | confidence 0.7500

Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

Online openbare raadpleging over de verlenging van het digitaal EU-covidcertificaat
Online public consultation on the extension of the EU Digital COVID Certificate

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer parliamentary_questions

Canonical identifier P-9-2022-001264

Official source URL https://data.europarl.europa.eu/eli/dl/doc/P-9-2022-001264

Title and language layer English primary, Dutch fallback

EP term 9

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: -

Keywords: Online public consultation on the extension of the EU Digital COVID Certificate

Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News

Supporting layers Signals

Signals

topic-match / pfizer-covid

Value: 0.8000

Online openbare raadpleging over de verlenging van het digitaal EU-covidcertificaat Online public consultation on the extension of the EU Digital COVID Certificate Milan Uhrík; Jean-François Jalkh; Marco Campomenosi; Ladislav Ilčić; Gerolf

Linked vote events Votes and seat distribution

Linked vote events

No official vote items linked to this dossier yet.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard